Investment
Features
FeesSafety
Academy
More
Pluang+

Compare LifeStance Health Group Inc. Common Stock (LFST) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

LifeStance Health Group Inc. Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

LifeStance Health Group Inc. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? LifeStance Health Group Inc. Common Stock trades at $12.7 (market cap $4.69B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: LifeStance Health Group Inc. Common Stock is far larger — about 2.6× Vir Biotechnology Inc. Common Stock's market cap, and LifeStance Health Group Inc. Common Stock is trading nearer its 52-week high, Vir Biotechnology Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold LifeStance Health Group Inc. Common Stock for 6 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

LFSTVIR
Market Cap
$4.69B$1.80B
Volume
1,858,2201,782,836
Sector
HealthHealth
52-Week High
$13.38$11.78
52-Week Low
$4.81$5.12
Typical Hold Time
6 Days0 Days
Enterprise Value
$4.92B$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

LifeStance Health Group Inc. Common Stock

LifeStance Health Group (LFST) trades at $12.32, down 1.28% today, with strong technical momentum showing a bullish moving average signal. The company has consistently beaten earnings expectations in recent quarters, with Q2 2026 EPS of $0.06 exceeding the $0.03 forecast. Revenue growth accelerated from $1.42B in 2025 to $1.6B in 2026, while net income improved significantly from $9.66M to $51M.

Wall Street maintains strong bullish sentiment with 82% buy ratings and a $14.14 consensus price target representing 15% upside. However, elevated valuation multiples (P/E 94.8) and overbought technical conditions near 52-week highs warrant caution. The mental healthcare provider benefits from industry tailwinds but faces execution risks amid competitive pressures.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LFST

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

About LifeStance Health Group Inc. Common Stock

LifeStance Health provides outpatient mental healthcare, including therapy, psychiatry, and medication management services.

Read more on LFST →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →